Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
44.71
-0.27 (-0.60%)
Feb 12, 2026, 4:00 PM EST - Market closed

KNSA Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
174.86183.58107.95122.72122.47114.04
Short-Term Investments
177.2460.0598.4267.8959.73209.44
Cash & Short-Term Investments
352.1243.63206.37190.61182.2323.48
Cash Growth
57.34%18.05%8.27%4.61%-43.68%38.61%
Receivables
51.7441.7221.2720.323.99-
Inventory
41.426.3631.1221.63.68-
Prepaid Expenses
30.2920.0817.5410.546.599.56
Restricted Cash
-----0.21
Total Current Assets
475.53331.8276.3243.06196.45333.25
Property, Plant & Equipment
11.7311.0412.677.048.3810.62
Other Intangible Assets
15.516.2517.2518.2519.25-
Long-Term Deferred Tax Assets
201.29211.15219.28185.5-0.01
Other Long-Term Assets
8.2910.320.835.828.725.59
Total Assets
712.33580.55526.32459.67232.8349.46
Accounts Payable
6.152.048.257.91.870.5
Accrued Expenses
94.2280.5144.6730.1138.0329.2
Current Portion of Leases
2.71.992.253.33.382.11
Current Unearned Revenue
--0.31---
Other Current Liabilities
20.5216.088.195.751.540.04
Total Current Liabilities
123.59100.6263.6747.0744.8231.85
Long-Term Leases
7.027.8610.012.622.674.88
Long-Term Unearned Revenue
31.8131.8111.9512--
Other Long-Term Liabilities
14.531.821.861.840.270.81
Total Liabilities
176.95142.1287.4863.5247.7637.53
Common Stock
0.020.020.020.020.020.02
Additional Paid-In Capital
1,012959.72916.76888.12860.48829.42
Retained Earnings
-476.34-521.14-477.95-492.03-675.4-517.47
Comprehensive Income & Other
-0.16-0.160.010.04-0.07-0.03
Total Common Equity
535.38438.44438.84396.15185.04311.94
Shareholders' Equity
535.38438.44438.84396.15185.04311.94
Total Liabilities & Equity
712.33580.55526.32459.67232.8349.46
Total Debt
9.729.8612.265.926.056.99
Net Cash (Debt)
342.38233.77194.11184.69176.15316.5
Net Cash Growth
60.60%20.43%5.10%4.85%-44.34%37.17%
Net Cash Per Share
4.473.272.702.622.575.12
Filing Date Shares Outstanding
75.872.6470.6269.7569.168.23
Total Common Shares Outstanding
75.4272.5270.4669.769.0668.22
Working Capital
351.94231.18212.63195.99151.62301.4
Book Value Per Share
7.106.056.235.682.684.57
Tangible Book Value
519.88422.19421.59377.9165.79311.94
Tangible Book Value Per Share
6.895.825.985.422.404.57
Machinery
4.594.774.584.594.655.01
Construction In Progress
0.960.160.01-0.170.1
Leasehold Improvements
3.923.933.933.933.933.67
Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q